GH-axis research
GHRP-2
Peptídeo liofilizado de pesquisa de sinalização endócrina para revisão de sistemas
GHRP-2 is a growth hormone secretagogue research peptide studied around ghrelin-receptor activity and GH-release models.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesSomente para uso em pesquisa laboratorial. Não é para uso humano ou veterinário. Não se destina a diagnosticar, tratar, curar, mitigar ou prevenir doenças.
Mantenha selado, frio, seco e protegido de oscilações de calor. Confirme o armazenamento específico do produto na chegada.
Embalado para estabilidade de trânsito com suporte para pedidos disponível para rotas em clima quente.
Batch-linked certificate support is available through the documentation desk.
Contexto de pesquisa
Perfil de pesquisa de GHRP-2
GHRP-2 is a synthetic growth hormone secretagogue studied through the ghrelin receptor pathway. Research examines GH-release magnitude and timing, endocrine-response markers, receptor pharmacology, appetite-related observations, and comparisons with GHRP-6, ipamorelin, or GHRH analogs. Its experimental profile is not identical to ipamorelin, which is often studied for greater selectivity, or GHRP-6, which is frequently associated with stronger appetite-pathway observations. GHRP-2 is useful as an established secretagogue comparator in GH-axis work. Study design should separate direct GHS-R signaling from GHRH-receptor activity and should not translate endocrine findings into personal-use or treatment recommendations.
Molecular class
Six-residue GH secretagogue
Sequence / composition
D-Ala-D-beta-naphthylalanine-Ala-Trp-D-Phe-Lys-NH2; a short peptide with D-amino-acid substitutions.
Research design note
Its non-natural residues are part of the GHS-R pharmacology and should be distinguished from a native ghrelin sequence.
Mecanismo proposto
A synthetic agonist at GHS-R1a. It stimulates pituitary growth-hormone release and also engages hypothalamic ghrelin-related pathways; endocrine selectivity is lower than that reported for ipamorelin.
Efeitos relatados em estudos
- Human studies reported marked acute GH release, with responses influenced by dose, age, nutrition, and concurrent GHRH signaling.
- Studies also reported appetite-related effects and changes in ACTH, cortisol, or prolactin under some conditions.
- Repeated exposure can produce altered responsiveness or desensitization depending on the experimental schedule.
Desfechos comuns de pesquisa
GHS-R potency, GH peak and area under the curve, ACTH, cortisol, prolactin, food intake, glucose, receptor desensitization, and synergy experiments with GHRH.
Evidências e limitações
Human endocrine pharmacology and preclinical evidence exist, but long-term effects and catalog-product equivalence are not established.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
Where can I find product documentation?
Contact support with the product name and any relevant order or batch reference to request available documents.
How can I compare pack options?
Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.